Möchten Sie immer auf dem neuesten Stand bleiben?

MAPS names Betty Aldworth and Ismail Lourido Ali as Co-Executive Directors, bringing decades of drug policy expertise.

MAPS selects Changemark as CRO for $12.9M Phase 2 cannabis PTSD study in Veterans, advancing toward Q1 2026 treatment start.

Sanborn Map Company, Inc. Expands Geospatial Footprint and Deepens Collaboration with Google Maps Platform and Google Cloud Products through acquisition.

Enhanced Virtual Trip platform goes live with improved user experience and first selection of PS2025 session videosConference drew 8,000+ attendees, more than $1 million donated, and 1,100+ recurring...

Sanborn announces Jared Martin as General Manager of the Mapping Division. A former Sanborn executive, Martin has joined the company in a pivotal role.

PharmAla makes shipment to Yale, Agrees with Multidisciplinary Association for Psychedelic Studies to publicly post Investigator's Brochure for LaNeo MDMA

Nearly 60 Ukrainian therapists will attend the event at no cost, learning fundamentals and best practices for psychedelic-assisted therapieAlpha XR than 300 practitioners from more than 30 countries have...

Former U.S. Sen. Kyrsten Sinema, Former Ohio Rep. Tim Ryan, Dr. Bessel van der Kolk, Harriet de Wit, Ph.D, Paul Stamets, and other policymakers, researchers, Veterans, therapists, and thought leaders...

MAPS’ next Executive Director will be a bold movement leader and visionary responsible for implementing MAPS' new strategic impact plan, ensuring programmatic excellence, advancing global expansion,...

PharmAla partners with Merhavim and MAPS Israel for innovative MDMA PTSD clinical trial data sharing partnership in wake of Gaza Ceasefire